842 related articles for article (PubMed ID: 18043549)
21. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
22. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
Solà R; Alvarez MA; Ballesté B; Montoliu S; Rivera M; Miquel M; Cirera I; Morillas RM; Coll S; Planas R
Liver Int; 2006 Feb; 26(1):62-72. PubMed ID: 16420511
[TBL] [Abstract][Full Text] [Related]
23. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.
Merkel C; Bolognesi M; Angeli P; Noventa F; Caregaro L; Sacerdoti D; Gatta A
Am J Gastroenterol; 1989 Jul; 84(7):717-22. PubMed ID: 2787099
[TBL] [Abstract][Full Text] [Related]
24. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.
Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123
[TBL] [Abstract][Full Text] [Related]
26. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
28. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
[TBL] [Abstract][Full Text] [Related]
29. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
Romani F; Belli LS; Rondinara GF; DeCarlis L; Rimoldi P; Riolo F; Bellati G; Ideo G; Belli L
J Am Coll Surg; 1994 Apr; 178(4):379-84. PubMed ID: 8149037
[TBL] [Abstract][Full Text] [Related]
30. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
[TBL] [Abstract][Full Text] [Related]
31. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
[TBL] [Abstract][Full Text] [Related]
32. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
33. [Survival in patients with liver cirrhosis at the Durango, IMSS Regional General Hospital].
Rodríguez-Hernández H; Jacobo-Karam JS; Castañón-Santillán Mdel C; Arámbula-Chávez M; Martínez-Aguilar G
Gac Med Mex; 2002; 138(4):325-30. PubMed ID: 12200877
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
[TBL] [Abstract][Full Text] [Related]
35. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications.
Huo TI; Lin HC; Wu JC; Hou MC; Lee FY; Lee PC; Chang FY; Lee SD
Clin Transplant; 2006; 20(2):188-94. PubMed ID: 16640525
[TBL] [Abstract][Full Text] [Related]
36. ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis.
Haukeland JW; Schreiner LT; Lorgen I; Frigstad SO; Bang C; Raknerud N; Konopski Z
Scand J Gastroenterol; 2008; 43(10):1241-8. PubMed ID: 18609128
[TBL] [Abstract][Full Text] [Related]
37. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
[TBL] [Abstract][Full Text] [Related]
38. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
[TBL] [Abstract][Full Text] [Related]
39. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.
Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC
Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
